One-Year Outcomes of Critical Care Patients Post-COVID-19 Multisystem Inflammatory Syndrome in Children
- PMID: 34459875
- PMCID: PMC8406209
- DOI: 10.1001/jamapediatrics.2021.2993
One-Year Outcomes of Critical Care Patients Post-COVID-19 Multisystem Inflammatory Syndrome in Children
Abstract
This study examines 1-year outcomes of critical care patients in the UK after COVID-19 multisystem inflammatory syndrome in children.
Conflict of interest statement
Figures
References
-
- Whittaker E, Bamford A, Kenny J, et al. ; PIMS-TS Study Group and EUCLIDS and PERFORM Consortia . Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259-269. doi:10.1001/jama.2020.10369 - DOI - PMC - PubMed
-
- Davies P, Lillie J, Prayle A, et al. . Association between treatments and short-term biochemical improvements and clinical outcomes in post-severe acute respiratory syndrome coronavirus-2 inflammatory syndrome. Pediatr Crit Care Med. 2021;22(5):e285-e293. doi:10.1097/PCC.0000000000002728 - DOI - PMC - PubMed
-
- Feldstein LR, Tenforde MW, Friedman KG, et al. ; Overcoming COVID-19 Investigators . Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA. 2021;325(11):1074-1087. doi:10.1001/jama.2021.2091 - DOI - PMC - PubMed
-
- Penner J, Abdel-Mannan O, Grant K, et al. ; GOSH PIMS-TS MDT Group . 6-Month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study. Lancet Child Adolesc Health. 2021;5(7):473-482. doi:10.1016/S2352-4642(21)00138-3 - DOI - PubMed
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
